Dr. Xiangdong Hua 华向东
Chief Physician
Department of Hepatobiliary and Pancreatic Surgery, Ward 1, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of hepatobiliary and pancreatic tumors, ERCP technology, liver transplantation, and precise hepatectomy.
Dr. Hua is Chief Physician and Director of Hepatobiliary and Pancreatic Surgery at Liaoning Cancer Hospital & Institute. Holding a Master’s degree, Dr. Hua graduated from Dalian Medical University in 1987 and served as a visiting scholar at Austin Hospital and Geelong Hospital in Melbourne, Australia, studying liver transplantation and ERCP. Research focuses on surgical treatment of hepatobiliary and pancreatic tumors and ERCP applications.
Professional roles
- Vice Chair, Northern Liver Cancer Expert Committee, China International Exchange and Promotion Association for Medicine and Healthcare
- Vice Chair, Biliary Tract Branch, Liaoning Anti-Cancer Association
- Editorial Board Member, Journal of Liver Cancer
- Member, Geriatric Oncology Professional Committee, Chinese Life Science Society
Name order: in Chinese the family name comes first (Hua Xiangdong). Papers usually list the name as Xiangdong Hua or Hua X.
Selected publications
21 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Cancer Res Ther, 2022 (senior author): Preoperative tumor abnormal protein is a promising biomarker for predicting hepatocellular carcinoma oncological outcome following curative resection. PubMed 36647965
- Mol Cell Biochem, 2022 (senior author): Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer. PubMed 35362843
- Ann Transl Med, 2021 (senior author): Olaparib effectively treats local recurrence of extrahepatic cholangiocarcinoma in a patient harboring a BRCA2-inactivating mutation: a case report. PubMed 34734039
- World J Gastrointest Oncol, 2020 (senior author): Prognostic factors and therapeutic effects of different treatment modalities for colorectal cancer liver metastases. PubMed 33133385
- Biomed Res Int, 2020 (senior author): Phloretin Modulates Human Th17/Treg Cell Differentiation In Vitro via AMPK Signaling. PubMed 32802861
- Biomed Chromatogr, 2015 (first author): Simultaneous determination and pharmacokinetic study of gambogic acid and gambogenic acid in rat plasma after oral administration of Garcinia hanburyi extracts by LC-MS/MS. PubMed 25159917
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion